SS

Unisys Announces 2Q23 Results

Retrieved on: 
Tuesday, August 1, 2023

BLUE BELL, Pa., Aug. 1, 2023 /PRNewswire/ -- Unisys (NYSE: UIS) today reported financial results for the second quarter ended June 30, 2023.

Key Points: 
  • "Our second quarter results demonstrate continued improvement in the performance of our Ex-L&S Solutions," said Unisys Chair and CEO Peter A. Altabef.
  • Unisys will hold a conference call with the financial community on Wednesday, August 2, 2023, at 8 a.m.
  • The live, listen-only webcast, as well as the accompanying presentation materials, can be accessed on the Unisys Investor Website at www.unisys.com/investor .
  • In addition, domestic callers can dial 1-844-695-5518 and international callers can dial 1-412-902-6749 and provide the following conference passcode: Unisys Corporation Call.

Aetrex Footwear Continues Sales Growth Momentum With New Styles Inspired by Best Sellers

Retrieved on: 
Tuesday, August 1, 2023

Aetrex will debut new footwear constructions that expand on consumer favorite core, spring styles, which have contributed to the brand’s footwear category growth of 23% increase year-over-year, following last year’s 50% sales increase.

Key Points: 
  • Aetrex will debut new footwear constructions that expand on consumer favorite core, spring styles, which have contributed to the brand’s footwear category growth of 23% increase year-over-year, following last year’s 50% sales increase.
  • Styles include the Jillian sandal, the company’s top seller with an 8-year tenure, and Sydney wedge, which increased in sales volume this year by 35%.
  • We also sprinkled in trending colors and materials to inject new excitement and energy,” said Amy Egelja, VP of Footwear Design at Aetrex.
  • Existing styles like Whit and Marz see added colorways like champagne and beige, while new styles such as the Alyssa are introduced in black and cognac.

NORTHEAST INDIANA BANCORP, INC. ANNOUNCES CASH DIVIDEND AND NAMES DR. JULIE UTENDORF TO BOARD OF DIRECTORS

Retrieved on: 
Thursday, July 27, 2023

The dividend will be payable on August 24, 2023, to shareholders of record on August 11, 2023.

Key Points: 
  • The dividend will be payable on August 24, 2023, to shareholders of record on August 11, 2023.
  • Dr. Julie Utendorf was appointed to the Boards of Northeast Indiana Bancorp and First Federal Savings Bank in June of this year.
  • Bank President, CEO, and fellow board member, Michael Zahn, states, "We are excited and fortunate to have Julie join the Board.
  • Northeast Indiana Bancorp, Inc. is headquartered at 648 N. Jefferson Street, Huntington, Indiana.

Yamaha Unveils 2024 Proven Off-Road ATV and Side-by-Side Lineup

Retrieved on: 
Wednesday, July 26, 2023

The 2024 Yamaha Wolverine X2 1000 is available at Yamaha dealers nationwide, starting at a $17,999 MSRP for the R-Spec trim in White and Armor Gray.

Key Points: 
  • The 2024 Yamaha Wolverine X2 1000 is available at Yamaha dealers nationwide, starting at a $17,999 MSRP for the R-Spec trim in White and Armor Gray.
  • The 2024 YXZ1000R and YXZ1000R SS are available at Yamaha dealers nationwide starting at a $20,899 MSRP in Team Yamaha Blue.
  • 2024 Recreational and Utility ATV Lineup: Grizzly, Kodiak 700, and Kodiak 450
    Yamaha introduces the 2024 Recreational and Utility ATV lineup, designed to excel in a wide range of applications from heavy-duty ranch and farm work to exhilarating off-road adventures.
  • Embark on your adventure and learn more about Yamaha's 2024 Proven Off-Road lineup at YamahaOutdoors.com or by visiting your local Yamaha dealer.

Yamaha Unleashes the 2024 YXZ1000R SS, Redefining Pure Sport Performance with All-New Auto-Shift Technology and 6-Speed Transmission

Retrieved on: 
Wednesday, July 26, 2023

The highlight of the 2024 YXZ1000R SS is Yamaha's exclusive Auto-Shift Technology, featuring three modes of direct-connection, conveniently accessible via a dash-mounted dial.

Key Points: 
  • The highlight of the 2024 YXZ1000R SS is Yamaha's exclusive Auto-Shift Technology, featuring three modes of direct-connection, conveniently accessible via a dash-mounted dial.
  • The new YXZ1000R SS also showcases increased accessory integration with a higher electrical output and added accessory ports and plugs.
  • The technology offers three user-selected modes: Auto, Sport Auto, and Sport Shift, catering to different driving preferences and terrains.
  • The 2024 YXZ1000R and YXZ1000R SS are available at Yamaha dealers nationwide starting at a $20,899 MSRP in Team Yamaha Blue.

SS&C, U.K.'s National Health Service Shared Business Services Team Up to Deliver Digital Transformation to NHS

Retrieved on: 
Wednesday, July 26, 2023

WINDSOR, Conn., July 26, 2023 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced a partnership with NHS Shared Business Services (SBS), the leading provider of corporate services to the NHS in England. The agreement builds on SS&C's relationship with select NHS organizations to use intelligent automation within back-office processes. Through the extended agreement with NHS SBS, more NHS organizations can leverage automation to deliver better care, cut down patient waiting lists and improve the healthcare worker experience.  

Key Points: 
  • Through the extended agreement with NHS SBS, more NHS organizations can leverage automation to deliver better care, cut down patient waiting lists and improve the healthcare worker experience.
  • "Our thriving intelligent automation program is further enhanced by our partnership with SS&C Blue Prism, which already has a robust presence within the NHS," said James Parker, Automation Lead for NHS SBS.
  • "The integrability of their solutions supports our NHS customers who use different automation suppliers, facilitating data interoperability to meet the needs of NHS organizations."
  • Over 130 digital workers are deployed with NHS SBS to drive efficiency and enable staff to focus on more valuable, patient-centered work.

SS&C, U.K.'s National Health Service Shared Business Services Team Up to Deliver Digital Transformation to NHS

Retrieved on: 
Wednesday, July 26, 2023

WINDSOR, Conn., July 26, 2023 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced a partnership with NHS Shared Business Services (SBS), the leading provider of corporate services to the NHS in England. The agreement builds on SS&C's relationship with select NHS organizations to use intelligent automation within back-office processes. Through the extended agreement with NHS SBS, more NHS organizations can leverage automation to deliver better care, cut down patient waiting lists and improve the healthcare worker experience.  

Key Points: 
  • Through the extended agreement with NHS SBS, more NHS organizations can leverage automation to deliver better care, cut down patient waiting lists and improve the healthcare worker experience.
  • "Our thriving intelligent automation program is further enhanced by our partnership with SS&C Blue Prism, which already has a robust presence within the NHS," said James Parker, Automation Lead for NHS SBS.
  • "The integrability of their solutions supports our NHS customers who use different automation suppliers, facilitating data interoperability to meet the needs of NHS organizations."
  • Over 130 digital workers are deployed with NHS SBS to drive efficiency and enable staff to focus on more valuable, patient-centered work.

RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome: Findings Published in Prestigious Rheumatology Journal

Retrieved on: 
Tuesday, July 25, 2023

Rheumatology is the official journal of the British Society for Rheumatology which is published by Oxford University Press.

Key Points: 
  • Rheumatology is the official journal of the British Society for Rheumatology which is published by Oxford University Press.
  • The journal is currently included in 27 international databases and is a top journal in this field with an impact factor of 7.046 in 2021.
  • As a new drug with significant potential, telitacicept Phase II clinical study data has been published in top international journals, which is major proof of our research and development capabilities.
  • Telitacicept, a novel fully human TACI-Fc fusion protein, shows promise in inhibiting B cell maturation and reducing autoantibody production, offering significant potential disease activity control.

Infosys: Solid Q1 year on year revenue growth of 4.2% at 20.8% operating margins

Retrieved on: 
Thursday, July 20, 2023

BENGALURU, India, July 20, 2023 /PRNewswire/ -- Infosys (NSE: INFY), (BSE: INFY), (NYSE:INFY), a global leader in next-generation digital services and consulting, delivered $4,617 million in Q1 revenues with year on year growth of 4.2% and sequential growth of 1.0% in constant currency. Large deal TCV for the quarter was at $2.3 billion, with net new of 56.1%. Operating margin for the quarter was stable at 20.8%. ROE improved 180 bps to 32.8%. Attrition declined further to 17.3%. FY24 revenue guidance revised to 1.0%-3.5% and operating margin guidance retained at 20%-22%.

Key Points: 
  • Company's rigorous operational discipline including improved productivity measures and higher utilization helped margins for the quarter," said Nilanjan Roy, CFO.
  • Danske Bank recently signed a strategic collaboration with Infosys to accelerate the bank's digital transformation initiatives with speed and scale.
  • Infosys has the tools, experience, and expertise to support us in accelerating our transformation using cloud and AI technologies.
  • Together, we look forward to delivering innovative solutions that meet the evolving needs of our customers and drive growth for the future."

Infosys: Solid Q1 year on year revenue growth of 4.2% at 20.8% operating margins

Retrieved on: 
Thursday, July 20, 2023

BENGALURU, India, July 20, 2023 /PRNewswire/ -- Infosys (NSE: INFY), (BSE: INFY), (NYSE:INFY), a global leader in next-generation digital services and consulting, delivered $4,617 million in Q1 revenues with year on year growth of 4.2% and sequential growth of 1.0% in constant currency. Large deal TCV for the quarter was at $2.3 billion, with net new of 56.1%. Operating margin for the quarter was stable at 20.8%. ROE improved 180 bps to 32.8%. Attrition declined further to 17.3%. FY24 revenue guidance revised to 1.0%-3.5% and operating margin guidance retained at 20%-22%.

Key Points: 
  • Company's rigorous operational discipline including improved productivity measures and higher utilization helped margins for the quarter," said Nilanjan Roy, CFO.
  • Danske Bank recently signed a strategic collaboration with Infosys to accelerate the bank's digital transformation initiatives with speed and scale.
  • Infosys has the tools, experience, and expertise to support us in accelerating our transformation using cloud and AI technologies.
  • Together, we look forward to delivering innovative solutions that meet the evolving needs of our customers and drive growth for the future."